[vc_row][vc_column][vc_empty_space height="60px"][vc_column_text] Concept to Commercialization: NP Swabs in America Author: Ryan HayfordPublish Date: August 20, 2020 [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] [caption id="attachment_1810" align="alignright" width="380"] Nasal Swab Case Study[/caption] Eight weeks. That’s how long it took GKN Additive (Forecast 3D) to create an agile manufacturing plan for the nasopharyngeal swabs and immediately go-to-market for mass production. As of today, GKN Additive (Forecast 3D) has produced over 1 million FDA approved NP swabs, and now has the capacity to produce 100,000 swabs per day.  Utilizing